{"meta":{"query_hash":"8cebc2dd487b","filters":{"venue":"Current Hematologic Malignancy Reports"},"cohort_total":33,"direct_labels_cover":0,"predictions_cover":33,"exported":33,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/8cebc2dd487b","api":"https://metacan.xera.ac/api/v1/cohort?venue=Current+Hematologic+Malignancy+Reports"},"results":[{"id":"W1944062703","doi":"10.1007/s11899-015-0287-9","title":"Social Media and Myeloproliferative Neoplasms (MPN)—Focus on Twitter and the Development of a Disease-specific Community: #MPNSM","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"University of Texas MD Anderson Cancer Center; Incyte; National Cancer Institute; Gilead Sciences","keywords":"Social media; Medicine; Public relations; Citation; Focus group; Health care; Internet privacy; Political science; World Wide Web; Business; Computer science; Marketing","score_opus":0.1813166460235479,"score_gpt":0.373956349976804,"score_spread":0.19263970395325608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1944062703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075890627,0.98720926,0.000012502778,0.00041727323,0.00046029565,0.0035105136,0.00004327322,0.00006065886,0.00069717795],"genre_scores_gemma":[0.02351231,0.97358185,0.00028194848,0.000045475026,0.00018673306,0.0018573137,0.00040659233,0.000070537484,0.000057220826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99468046,0.0009439987,0.0021540064,0.0008738971,0.0008502546,0.00049737596],"domain_scores_gemma":[0.99538296,0.0012966809,0.0017075414,0.00083226885,0.0003427866,0.00043778002],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014374327,0.0010343196,0.0044063134,0.0002558894,0.00055094395,0.00007139623,0.00017199013,0.00033966286,0.000048341735],"category_scores_gemma":[0.00048735604,0.0005494899,0.00044834934,0.0002991372,0.00079302804,0.000055921973,0.00036024288,0.0010329989,0.000015897816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006975096,0.0022918882,0.004146323,0.03348304,0.0014700423,0.0016700319,0.014454689,6.070255e-8,1.9779824e-7,0.015861694,0.00972717,0.91619736],"study_design_scores_gemma":[0.0042841034,0.00032780628,0.0014646751,0.041911807,0.0033870684,0.0030557304,0.00053348235,0.0000018188148,0.000051509738,0.008340019,0.9354799,0.0011620767],"about_ca_topic_score_codex":0.0000029201706,"about_ca_topic_score_gemma":0.000011189213,"teacher_disagreement_score":0.92575276,"about_ca_system_score_codex":0.00020373886,"about_ca_system_score_gemma":0.0010032268,"threshold_uncertainty_score":0.99969566},"labels":[],"label_agreement":null},{"id":"W1946581526","doi":"10.1007/s11899-015-0286-x","title":"Social Media and the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Aurora Research Institute; American Association for Cancer Research","keywords":"Social media; Microblogging; Workflow; Public relations; Internet privacy; Hematologist; Health care; Medicine; Medical education; World Wide Web; Computer science; Internal medicine; Political science","score_opus":0.4678624804527811,"score_gpt":0.5264026431069447,"score_spread":0.05854016265416362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1946581526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023588453,0.94861126,0.00004816282,0.020844512,0.016686322,0.013339873,0.000011611113,0.00015212371,0.00028252037],"genre_scores_gemma":[0.0006590991,0.9775695,0.00010667268,0.00016523094,0.0034581022,0.017856581,0.00007410988,0.00006070039,0.000050007362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99273866,0.002233037,0.002019076,0.0009343147,0.0010400842,0.0010348017],"domain_scores_gemma":[0.9740028,0.020407813,0.003875738,0.00068113767,0.00073663366,0.00029590857],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.008693935,0.0005946799,0.002567715,0.00011572379,0.0023825716,0.00024389032,0.000584613,0.00077600934,0.000026603626],"category_scores_gemma":[0.035359237,0.00031653498,0.0005414609,0.0006504477,0.0018134092,0.00018059036,0.00018560431,0.0009891063,0.000012700553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018669394,0.00008273957,0.00039298664,0.025369355,0.00008880107,0.000047597397,0.03845412,1.861996e-8,1.2953659e-9,0.04998305,0.028904796,0.85665786],"study_design_scores_gemma":[0.00022261696,0.000011493911,0.000009147038,0.0039017787,0.00074280985,0.00039415347,0.0050025275,8.6290385e-7,6.333309e-8,0.01960693,0.9697535,0.00035411227],"about_ca_topic_score_codex":0.00072109874,"about_ca_topic_score_gemma":0.00056876044,"teacher_disagreement_score":0.9408487,"about_ca_system_score_codex":0.0005022519,"about_ca_system_score_gemma":0.0045071547,"threshold_uncertainty_score":0.99992865},"labels":[],"label_agreement":null},{"id":"W2007505304","doi":"10.1007/s11899-014-0213-6","title":"Which Hodgkin’s Patients in the Unites States Should Be Treated with BEACOPP?","year":2014,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"ABVD; Medicine; Procarbazine; Dacarbazine; Vinblastine; Oncology; Internal medicine; Hodgkin's lymphoma; Regimen; Vincristine; Chemotherapy; Cyclophosphamide","score_opus":0.03486173526679406,"score_gpt":0.2923363232740295,"score_spread":0.25747458800723544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007505304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289984,0.0011761647,0.0000120212535,0.0011900647,0.00013198455,0.0010971113,0.000008758903,0.00009595973,0.0033881064],"genre_scores_gemma":[0.9982179,0.00032527532,0.00009313742,0.0003669881,0.00003147387,0.00037426694,0.0005171256,0.000021589289,0.000052262683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976724,0.00014788774,0.0006385483,0.0005620522,0.0005335477,0.00044560162],"domain_scores_gemma":[0.9983744,0.00021870053,0.00035164296,0.0007172462,0.00021027494,0.00012770882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036126678,0.00035366093,0.0006076245,0.00013262565,0.000103084356,0.000041889,0.00010739855,0.000105350424,0.00007247883],"category_scores_gemma":[0.00023598775,0.00017579155,0.00009180204,0.0005212029,0.00007614406,0.00007519158,0.000041845076,0.00016882227,0.000011688238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049684426,0.0020393091,0.9900486,0.00016849532,0.000046477944,0.0006543185,0.00031828583,0.000004335351,0.000003721285,0.00053256616,0.0042026737,0.001931528],"study_design_scores_gemma":[0.0032441434,0.0012062605,0.969393,0.0012008572,0.0003341622,0.0016035541,0.00021026282,0.000065429704,0.002056725,0.0007435111,0.019549618,0.00039248465],"about_ca_topic_score_codex":0.00013981714,"about_ca_topic_score_gemma":0.00012490498,"teacher_disagreement_score":0.020655612,"about_ca_system_score_codex":0.00009580651,"about_ca_system_score_gemma":0.00007805063,"threshold_uncertainty_score":0.71685714},"labels":[],"label_agreement":null},{"id":"W2008576749","doi":"10.1007/s11899-013-0183-0","title":"Multiple Myeloma: Defining the High-Risk Patient and Determining the Optimal Treatment Strategy","year":2013,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Multiple myeloma; Medicine; Bortezomib; Hematology; Internal medicine; Malignancy; Hematologic malignancy; Intensive care medicine; Clinical trial; Oncology","score_opus":0.07505719191943697,"score_gpt":0.3537867960608366,"score_spread":0.2787296041413996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008576749","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03408786,0.9592628,0.0000129475375,0.000031557534,0.00053568423,0.005632632,0.0000844117,0.000112231195,0.00023990039],"genre_scores_gemma":[0.05713697,0.9387055,0.0003013249,0.000009726957,0.000108485845,0.0030083545,0.0005240897,0.0000828691,0.00012265482],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99481946,0.00053300173,0.0016707795,0.0012066289,0.0006878591,0.0010822735],"domain_scores_gemma":[0.99510276,0.0011090221,0.0017223245,0.0014812885,0.00019054401,0.00039404636],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043437802,0.0010859942,0.0025810897,0.00016557777,0.0007536434,0.00019110422,0.00023265778,0.00033686103,0.000121390214],"category_scores_gemma":[0.0007535279,0.0004464371,0.0007199268,0.000290532,0.00033466137,0.00009646829,0.00036195866,0.0007776644,0.000107172265],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015444562,0.00041947947,0.016735978,0.003337613,0.00055508444,0.0018986401,0.00010839118,0.0000011769596,7.3618224e-8,0.00012243842,0.0003756648,0.97643],"study_design_scores_gemma":[0.003094836,0.0026121016,0.0060263346,0.023287302,0.007043271,0.021737315,0.00029257778,0.00021067087,0.000041658393,0.0002454713,0.93396604,0.0014424109],"about_ca_topic_score_codex":0.00012846637,"about_ca_topic_score_gemma":0.000014073413,"teacher_disagreement_score":0.9749876,"about_ca_system_score_codex":0.00027757254,"about_ca_system_score_gemma":0.00054987066,"threshold_uncertainty_score":0.9997987},"labels":[],"label_agreement":null},{"id":"W2014255239","doi":"10.1007/s11899-009-0030-5","title":"Update on the World Health Organization classification of peripheral T-cell lymphomas","year":2009,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Lymphoproliferative disorders; Hematology; Medicine; Phenotype; Pathology; Not Otherwise Specified; Oncology; Peripheral T-cell lymphoma; Internal medicine; T cell; Immunology; Biology; Gene; Genetics; Immune system","score_opus":0.07503516850817778,"score_gpt":0.35915129264967016,"score_spread":0.2841161241414924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014255239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026256128,0.99271125,0.000014444382,0.00083110906,0.0006467903,0.0025524623,0.000017343558,0.00010566097,0.00285839],"genre_scores_gemma":[0.009789083,0.98807436,0.000087565684,0.00017736638,0.00010123032,0.00023553002,0.0010855293,0.00005174712,0.00039758874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99611807,0.0002515693,0.0019304341,0.0007883079,0.00052212016,0.0003894875],"domain_scores_gemma":[0.9952505,0.00015519848,0.0029725062,0.0012408657,0.00021120317,0.0001696922],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000410666,0.00060992857,0.0024614045,0.00023928605,0.00015510798,0.00003336428,0.00016206832,0.00020110226,0.00037076065],"category_scores_gemma":[0.00017315945,0.00033544996,0.00053419464,0.0009565551,0.000078918674,0.000038776067,0.00005078131,0.00022222323,0.00006313045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008972374,0.0030132036,0.0038487636,0.022423837,0.00015868606,0.00053548464,0.00004872501,3.0290119e-7,7.4268627e-7,0.014095834,0.026956728,0.9289087],"study_design_scores_gemma":[0.00038302183,0.00021410127,0.00088204106,0.030165065,0.00081753737,0.0019892722,0.000010483558,0.0000019006229,0.00009650151,0.0002648614,0.9648575,0.00031767073],"about_ca_topic_score_codex":0.0000054951447,"about_ca_topic_score_gemma":0.0000028031063,"teacher_disagreement_score":0.93790084,"about_ca_system_score_codex":0.0006900836,"about_ca_system_score_gemma":0.001195289,"threshold_uncertainty_score":0.99990976},"labels":[],"label_agreement":null},{"id":"W2017131345","doi":"10.1007/s11899-012-0139-9","title":"“Antivirals” in the Treatment of Adult T Cell Leukaemia– Lymphoma (ATLL)","year":2012,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Zidovudine; Lymphoma; Oncology; Immunology; Hematology; Virus; Gastroenterology; Viral disease","score_opus":0.06301480317142466,"score_gpt":0.31239457870223897,"score_spread":0.2493797755308143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017131345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028024737,0.98875535,0.0000023800155,0.000009967565,0.0035602201,0.0015844236,0.000053836353,0.00005937686,0.0031720037],"genre_scores_gemma":[0.022290494,0.9757478,0.000008681415,0.000007640526,0.0000787028,0.0005866034,0.00032215673,0.000036396636,0.00092152244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99554515,0.00066131266,0.0020479588,0.0007805879,0.00011439201,0.0008505964],"domain_scores_gemma":[0.9964041,0.00036529818,0.002023072,0.001088162,0.00008921289,0.000030122586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034372302,0.0009021739,0.0034698418,0.00024898179,0.00017746349,0.000012810915,0.00041566996,0.0007739177,0.00013240371],"category_scores_gemma":[0.00005519868,0.00045491123,0.0011265082,0.00038732716,0.00038724908,0.00005458319,0.00012435234,0.00030717233,0.00028519073],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014657122,0.004195331,0.0036800767,0.018541912,0.00037443655,0.00069250504,0.0009803501,4.1300368e-8,0.000040290197,0.0008415448,0.0021584441,0.9684804],"study_design_scores_gemma":[0.0004689955,0.00021432574,0.000038657447,0.0047173114,0.0012237908,0.0027736702,0.00011775564,1.482759e-8,0.0008166527,0.00011324641,0.98902756,0.0004880391],"about_ca_topic_score_codex":0.00007842853,"about_ca_topic_score_gemma":0.000018475252,"teacher_disagreement_score":0.9868691,"about_ca_system_score_codex":0.00015796721,"about_ca_system_score_gemma":0.00022776164,"threshold_uncertainty_score":0.99979025},"labels":[],"label_agreement":null},{"id":"W2022946612","doi":"10.1007/s11899-014-0214-5","title":"Chemotherapy Only in Early Stage Hodgkin Lymphoma: More Relapses but the Same Survival – What to Do?","year":2014,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"ABVD; Medicine; Lymphoma; Stage (stratigraphy); Hodgkin's lymphoma; Chemotherapy; Radiation therapy; Hodgkin lymphoma; Internal medicine; Dacarbazine; Randomized controlled trial; Survival rate; Positron emission tomography; Oncology; Surgery; Radiology; Vincristine; Cyclophosphamide","score_opus":0.024286227314749415,"score_gpt":0.3011997911824983,"score_spread":0.2769135638677489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022946612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838459,0.008438315,0.00005533407,0.0034956248,0.0015832379,0.0014117219,0.0000064678175,0.00012252436,0.0010408643],"genre_scores_gemma":[0.9959638,0.0020048327,0.00018209722,0.00079231727,0.00013884922,0.00024047955,0.00003370401,0.00004222819,0.00060167565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967336,0.00015433735,0.00094237743,0.0008815321,0.0006421818,0.00064599345],"domain_scores_gemma":[0.9977357,0.00021853858,0.00041426666,0.0012328019,0.00012599409,0.0002727443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070992566,0.0004678371,0.0009441758,0.00016108039,0.00012394754,0.0001566663,0.00019561712,0.00016753464,0.00014031454],"category_scores_gemma":[0.0003402293,0.0002851472,0.00026297214,0.0004158383,0.00010603711,0.00019497515,0.00011800012,0.00014244548,0.00007452319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011520835,0.0016152853,0.909737,0.00020027952,0.00007548851,0.002608219,0.0012652605,0.0000041990743,0.000045017387,0.003066776,0.0016833196,0.07958399],"study_design_scores_gemma":[0.0036890714,0.0005382037,0.9401551,0.0021827673,0.000118365606,0.0029250225,0.0012929295,0.000018790033,0.0048546637,0.0015396331,0.042098366,0.0005870974],"about_ca_topic_score_codex":0.00023859374,"about_ca_topic_score_gemma":0.000050842078,"teacher_disagreement_score":0.07899689,"about_ca_system_score_codex":0.00023977367,"about_ca_system_score_gemma":0.00023554801,"threshold_uncertainty_score":0.99996006},"labels":[],"label_agreement":null},{"id":"W2024403341","doi":"10.1007/s11899-013-0163-4","title":"Hodgkin Lymphoma in Pregnancy","year":2013,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Pregnancy; Vinblastine; Lymphoma; Intensive care medicine; Disease; Hodgkin lymphoma; Chemotherapy; Internal medicine; Pediatrics; Obstetrics","score_opus":0.030985646590251492,"score_gpt":0.3045995390588377,"score_spread":0.2736138924685862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024403341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963698,0.027171984,0.00006938735,0.0003137189,0.0012078523,0.0013586284,0.0000020669925,0.00016639223,0.006011921],"genre_scores_gemma":[0.99759483,0.0012359361,0.0001820366,0.000071181435,0.00006318689,0.00041196495,0.00002759986,0.000024717847,0.0003885724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977084,0.000033370456,0.0008501238,0.00058470963,0.00031362317,0.00050981704],"domain_scores_gemma":[0.99870014,0.000032119624,0.0003194331,0.0006380373,0.00010389059,0.00020635479],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011973786,0.00027646543,0.00063594285,0.00018261568,0.000044716355,0.0000298245,0.00008204772,0.000141714,0.0012958453],"category_scores_gemma":[0.0001471403,0.00021208568,0.00017343927,0.0003502152,0.00007509685,0.00014887366,0.000071595714,0.0001618452,0.00015482912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012081998,0.00054236955,0.86211807,0.00046724454,0.000016765262,0.0024218645,0.00014777595,6.6515474e-7,0.0002711444,0.0005394743,0.0055047283,0.1279578],"study_design_scores_gemma":[0.0022308058,0.0002463549,0.93213606,0.0059363847,0.000084485284,0.0087867575,0.00013521548,0.00008956693,0.004963141,0.009708955,0.034911253,0.0007710414],"about_ca_topic_score_codex":0.0002236453,"about_ca_topic_score_gemma":0.000016544976,"teacher_disagreement_score":0.12718678,"about_ca_system_score_codex":0.00012933562,"about_ca_system_score_gemma":0.00016230326,"threshold_uncertainty_score":0.9996171},"labels":[],"label_agreement":null},{"id":"W2045989969","doi":"10.1007/s11899-008-0030-x","title":"Novel therapies in peripheral T-cell lymphomas","year":2008,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Hematology; Oncology; Internal medicine; Lymphoma; Peripheral T-cell lymphoma; Bioinformatics; T cell; Immunology; Biology; Immune system","score_opus":0.07527003511942738,"score_gpt":0.3469950288066572,"score_spread":0.27172499368722985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045989969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00066823646,0.9909198,0.000008903094,0.000029595813,0.0013182389,0.0023852212,0.000020305944,0.00016248642,0.0044871755],"genre_scores_gemma":[0.0017160298,0.9954708,0.00035074545,0.00003332605,0.00015477484,0.0013132944,0.00038678088,0.000089534755,0.00048470264],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995171,0.00010286322,0.002125674,0.0013041733,0.00054542936,0.00075086864],"domain_scores_gemma":[0.9970626,0.00013247099,0.0012710278,0.001182094,0.00009564712,0.00025612343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016917812,0.0010840766,0.0043877997,0.00036661845,0.00010417302,0.0000372095,0.00017628325,0.00055465987,0.00029294225],"category_scores_gemma":[0.00008896111,0.0007205428,0.0013485604,0.00053235184,0.00014423806,0.00007449892,0.00013324808,0.00035556758,0.000077612596],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015153144,0.00644659,0.019601887,0.035480317,0.00030991322,0.03544865,0.00020925124,2.1765418e-7,0.0000013583941,0.00034347715,0.0039537456,0.8981894],"study_design_scores_gemma":[0.0012176222,0.000117982876,0.00037270237,0.030470472,0.00056296174,0.064896375,0.000014437179,9.309357e-7,0.000016127364,0.00007054565,0.901632,0.0006278414],"about_ca_topic_score_codex":0.00003629225,"about_ca_topic_score_gemma":0.000004828343,"teacher_disagreement_score":0.89767826,"about_ca_system_score_codex":0.00077804166,"about_ca_system_score_gemma":0.0012380356,"threshold_uncertainty_score":0.9995246},"labels":[],"label_agreement":null},{"id":"W2052924000","doi":"10.1007/s11899-007-0022-2","title":"Is BEACOPP better than ABVD?","year":2007,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"ABVD; Procarbazine; Medicine; Dacarbazine; Vincristine; Oncology; Vinblastine; Prednisone; Internal medicine; Cyclophosphamide; Chemotherapy","score_opus":0.14328563488198798,"score_gpt":0.41713827398589703,"score_spread":0.27385263910390906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052924000","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021559637,0.9906241,0.00003115482,0.00010785048,0.0023749112,0.0025990424,0.000039034167,0.00023961447,0.0037686576],"genre_scores_gemma":[0.00029848237,0.9960502,0.0003649493,0.00023779181,0.00043160128,0.0006996829,0.00071530545,0.00010059003,0.0011014374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99426156,0.00008732635,0.0023719282,0.0015710392,0.0007831602,0.0009249736],"domain_scores_gemma":[0.99581605,0.00017193536,0.0016712402,0.0017500406,0.00016213758,0.0004285979],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004336018,0.0011801542,0.0045307563,0.00040701657,0.0001269442,0.000075261894,0.00019298228,0.0007623023,0.0005542011],"category_scores_gemma":[0.00011399546,0.000763792,0.0020347224,0.0004871582,0.00012337258,0.000099101824,0.00019161339,0.0005084653,0.00047489704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000053842614,0.0011435401,0.013516734,0.03857718,0.0005092877,0.025561797,0.000029959416,2.4324318e-9,6.750819e-8,0.0003316156,0.031598564,0.8887259],"study_design_scores_gemma":[0.00037838108,0.00011291668,0.00021579297,0.05484532,0.0031852634,0.03046706,0.0000034204777,1.1146088e-7,0.000044353594,0.00037577318,0.90974593,0.0006256891],"about_ca_topic_score_codex":0.000011238511,"about_ca_topic_score_gemma":0.0000012783167,"teacher_disagreement_score":0.8881002,"about_ca_system_score_codex":0.00042715474,"about_ca_system_score_gemma":0.0005947284,"threshold_uncertainty_score":0.9994813},"labels":[],"label_agreement":null},{"id":"W2062299904","doi":"10.1007/s11899-011-0100-3","title":"Update: Peripheral T-Cell Lymphomas","year":2011,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Hematology; Peripheral T-cell lymphoma; Oncology; Internal medicine; Disease; T-cell lymphoma; Peripheral; T cell; Pathology; Immunology; Immune system","score_opus":0.07608571854870042,"score_gpt":0.3457742507995178,"score_spread":0.26968853225081735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062299904","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009275743,0.97629285,0.000008626071,0.000015730842,0.002580801,0.002452415,0.000029295672,0.000315916,0.018211603],"genre_scores_gemma":[0.00059948105,0.99533725,0.00030404457,0.00004482912,0.00024342065,0.00129809,0.00090516324,0.00011981102,0.0011478981],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994744,0.00014644723,0.002215964,0.001562693,0.00046555194,0.0008653309],"domain_scores_gemma":[0.9956842,0.000066189976,0.0017895317,0.0018054881,0.00015494683,0.0004996114],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026493537,0.0012684856,0.004700146,0.0002628756,0.00014240634,0.000056448323,0.0002366135,0.0006741556,0.0021782727],"category_scores_gemma":[0.00008434121,0.0008322091,0.0018907423,0.00039928462,0.00013870854,0.00008526207,0.0002335022,0.00036328944,0.00066151866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011411324,0.0027497069,0.003479491,0.053045157,0.00036423147,0.020453459,0.000038024693,1.1479527e-8,9.6887e-8,0.0014845663,0.016278625,0.9020952],"study_design_scores_gemma":[0.00061499764,0.0001433238,0.000040776777,0.0257851,0.0034333328,0.035320584,0.0000049307946,2.6468845e-7,0.00002704867,0.00031866264,0.93358976,0.0007212259],"about_ca_topic_score_codex":0.000014856072,"about_ca_topic_score_gemma":0.0000010217565,"teacher_disagreement_score":0.91731113,"about_ca_system_score_codex":0.00058689754,"about_ca_system_score_gemma":0.0012379063,"threshold_uncertainty_score":0.9994129},"labels":[],"label_agreement":null},{"id":"W2191051211","doi":"10.1007/s11899-015-0296-8","title":"Myelofibrosis—When Do We Select Transplantation or Non-transplantation Therapeutic Options?","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Myelofibrosis; Transplantation; Ruxolitinib; Hematology; Internal medicine; Hematopoietic stem cell transplantation; Janus kinase; Oncology; Intensive care medicine; Disease; Bone marrow","score_opus":0.11694056028219584,"score_gpt":0.39379647031905823,"score_spread":0.2768559100368624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191051211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016933757,0.99188155,0.0006327026,0.00012911954,0.0012127175,0.0048792926,0.00014656511,0.00023450627,0.00071423926],"genre_scores_gemma":[0.0007703012,0.9919881,0.00094322866,0.000031431693,0.00022882044,0.0026440585,0.002840402,0.00011399194,0.0004396558],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944998,0.0003347655,0.0022008754,0.0014101928,0.00087244174,0.00068194413],"domain_scores_gemma":[0.9966295,0.0002822543,0.0014432379,0.0008639542,0.0003855003,0.00039560173],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056671485,0.0011801388,0.0036019438,0.0004516564,0.00020301554,0.00010816654,0.00016947591,0.0006272614,0.00054448575],"category_scores_gemma":[0.000058017806,0.0007368177,0.0008554251,0.0005956972,0.00010109418,0.00017695189,0.000029004044,0.0005861571,0.00017253424],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020498963,0.0013126301,0.0015013015,0.09944886,0.0009691918,0.009335808,0.0006921481,0.0000013676524,0.0000028318884,0.00074464583,0.0041689663,0.88161725],"study_design_scores_gemma":[0.0012780642,0.00068449177,0.0001361771,0.071814924,0.010151558,0.046682417,0.000024822257,0.0000058896576,0.00013134805,0.0011841321,0.86692953,0.0009766408],"about_ca_topic_score_codex":0.000008845629,"about_ca_topic_score_gemma":0.0000086247055,"teacher_disagreement_score":0.8806406,"about_ca_system_score_codex":0.00038004736,"about_ca_system_score_gemma":0.001459809,"threshold_uncertainty_score":0.99950826},"labels":[],"label_agreement":null},{"id":"W2287622513","doi":"10.1007/s11899-016-0313-6","title":"Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada","funders":"National Cancer Institute","keywords":"Medicine; Young adult; Cancer; Breast cancer; Incidence (geometry); Population; Social media; Oncology; Internal medicine; Pediatrics; Gerontology","score_opus":0.05691916317588371,"score_gpt":0.35652611882657814,"score_spread":0.29960695565069445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287622513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009058152,0.992946,0.000018144296,0.001243932,0.0016952669,0.002698459,0.000058874004,0.00011541137,0.00031804113],"genre_scores_gemma":[0.0033851927,0.9947018,0.000028948694,0.00018790147,0.0006359751,0.0008594985,0.000070549555,0.000077975674,0.00005214374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951337,0.0004002569,0.0017830195,0.0011769471,0.00091846293,0.0005876451],"domain_scores_gemma":[0.9961275,0.00036012303,0.0021933026,0.00073773996,0.00028408444,0.0002972346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063537474,0.0008539365,0.0037203636,0.00012830543,0.00024893592,0.000058451456,0.0001406152,0.00035528856,0.000075916294],"category_scores_gemma":[0.0005638796,0.00039731548,0.00042601072,0.00023280462,0.00084069866,0.000068727895,0.00025551763,0.00067937444,0.0000062715317],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001423355,0.00024702915,0.0039004888,0.06502989,0.00044561425,0.001476338,0.0022086985,3.6929149e-9,5.3018606e-8,0.0020400542,0.008030033,0.91647947],"study_design_scores_gemma":[0.002394387,0.00010837354,0.0004397011,0.1952071,0.0032160827,0.025018008,0.00020190337,4.189572e-7,0.0000036010115,0.0008629622,0.7715134,0.0010340585],"about_ca_topic_score_codex":0.000059220292,"about_ca_topic_score_gemma":0.000116692936,"teacher_disagreement_score":0.9154454,"about_ca_system_score_codex":0.00015647773,"about_ca_system_score_gemma":0.0006507966,"threshold_uncertainty_score":0.9998479},"labels":[],"label_agreement":null},{"id":"W2309364123","doi":"10.1007/s11899-016-0317-2","title":"Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Hematology; Chemotherapy; Hematopoietic cell; Transplantation; Oncology; Hematopoietic stem cell transplantation; Internal medicine; Lymphoblastic Leukemia; Young adult; Acute lymphocytic leukemia; Leukemia; Intensive care medicine; Pediatrics; Haematopoiesis; Stem cell","score_opus":0.03268983140793776,"score_gpt":0.3511645003849713,"score_spread":0.3184746689770336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2309364123","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004542545,0.98727757,0.002447846,0.000027269578,0.0014476796,0.00699769,0.00020405286,0.00022105363,0.00092260726],"genre_scores_gemma":[0.001031933,0.992919,0.00049561245,0.000020571451,0.00020442266,0.0033459484,0.0010979731,0.00019934041,0.0006852004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99218357,0.00019870135,0.0032784964,0.0019533746,0.00094438053,0.001441492],"domain_scores_gemma":[0.9951135,0.0010470549,0.0016906523,0.0013613863,0.000303626,0.0004837785],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006820935,0.0012514642,0.0047621354,0.0008718675,0.00011379376,0.000045695168,0.0004047482,0.0010340172,0.00020180868],"category_scores_gemma":[0.0004642284,0.0008380276,0.0012947456,0.00075660285,0.00021216372,0.00014799998,0.00013685103,0.0006222955,0.0002305676],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00045338768,0.00052384863,0.00026540813,0.4708794,0.00040102887,0.027040014,0.00020597772,7.7101345e-7,0.000007657714,0.00055413204,0.005211154,0.49445722],"study_design_scores_gemma":[0.006557461,0.0005508871,0.000026830316,0.42629534,0.005226037,0.078104414,0.00002286867,0.00006522953,0.00020342857,0.0016390806,0.4794571,0.0018513297],"about_ca_topic_score_codex":0.000009250012,"about_ca_topic_score_gemma":0.0000031427903,"teacher_disagreement_score":0.4926059,"about_ca_system_score_codex":0.0040481393,"about_ca_system_score_gemma":0.0066435575,"threshold_uncertainty_score":0.9997752},"labels":[],"label_agreement":null},{"id":"W2409124043","doi":"10.1007/s11899-016-0333-2","title":"Value Based Care and Patient-Centered Care: Divergent or Complementary?","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Value (mathematics); Health care; Quality (philosophy); Incentive; Medicine; Preference; Payment; Value-Based Purchasing; Reimbursement; Nursing; Family medicine; Business; Computer science; Economics; Microeconomics","score_opus":0.09273398251352287,"score_gpt":0.31652480232982744,"score_spread":0.22379081981630455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409124043","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014181306,0.9877734,0.00021206899,0.000037132428,0.0043152687,0.0017838299,0.0020041934,0.00009241602,0.003639889],"genre_scores_gemma":[0.0026166674,0.9957335,0.00024723314,0.000094941664,0.00016527949,0.00037135184,0.0006110977,0.000090071015,0.00006985905],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945137,0.000059749913,0.0029447118,0.001580353,0.00009835271,0.0008031257],"domain_scores_gemma":[0.9951411,0.00010014692,0.003327704,0.0010523932,0.000110086265,0.0002685632],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020250138,0.0009069112,0.0034469585,0.00039566177,0.0002366464,0.00012276777,0.00036023516,0.000380501,0.001098814],"category_scores_gemma":[0.00018927413,0.00069482916,0.0007958192,0.00023078844,0.00015557407,0.0002351749,0.00035167212,0.00030843532,0.000230286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000175193,0.000114033246,0.0044867904,0.027472178,0.0001476083,0.0005620458,0.00037699466,4.239867e-7,1.28824285e-8,0.009962417,0.005857824,0.9510022],"study_design_scores_gemma":[0.00044215444,0.00017638742,0.000032442193,0.017696956,0.00012712262,0.0002955654,0.00006370029,0.0000014951016,0.000002081295,0.0015489362,0.9786791,0.00093406485],"about_ca_topic_score_codex":0.00004735898,"about_ca_topic_score_gemma":0.000014005164,"teacher_disagreement_score":0.9728213,"about_ca_system_score_codex":0.0006476768,"about_ca_system_score_gemma":0.00032264047,"threshold_uncertainty_score":0.99981433},"labels":[],"label_agreement":null},{"id":"W2482129219","doi":"10.1007/s11899-016-0340-3","title":"Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; European Hematology Association","keywords":"Social media; Hematology; The Internet; Hematologic malignancy; Medicine; Cancer; Internal medicine; Family medicine; Computer science; World Wide Web","score_opus":0.04298612721636083,"score_gpt":0.33799098968274327,"score_spread":0.29500486246638247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482129219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010585765,0.98339057,0.00009495806,0.000033544038,0.00060122693,0.004485847,0.00014882474,0.00012586905,0.0005333765],"genre_scores_gemma":[0.014723136,0.9818535,0.00013301588,0.000013763464,0.00028782102,0.001415973,0.0006405221,0.00018499374,0.00074726035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950139,0.00019151317,0.0015346903,0.0014392906,0.0008722746,0.00094835943],"domain_scores_gemma":[0.996038,0.0013303959,0.0011844677,0.00055245776,0.00051638216,0.00037830198],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002829858,0.00096292765,0.0033072832,0.0004221909,0.00019735722,0.00008957608,0.00022340301,0.0004922099,0.000161035],"category_scores_gemma":[0.0013535818,0.0005830492,0.00051378674,0.00027895998,0.00047463962,0.00007572761,0.0002500248,0.00049193023,0.00004498868],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005890394,0.002266316,0.020412624,0.22314034,0.0007755182,0.0057119695,0.0012429483,3.1820527e-8,0.000001280227,0.00041834082,0.011515414,0.7339262],"study_design_scores_gemma":[0.0026534407,0.0006963545,0.00013140799,0.054935038,0.001729503,0.014503887,0.00004789932,0.0000041222543,0.000015157178,0.0006544254,0.9234837,0.001145047],"about_ca_topic_score_codex":0.0000018259354,"about_ca_topic_score_gemma":0.000009097111,"teacher_disagreement_score":0.9119683,"about_ca_system_score_codex":0.00024600097,"about_ca_system_score_gemma":0.0006619429,"threshold_uncertainty_score":0.9996621},"labels":[],"label_agreement":null},{"id":"W2483061118","doi":"10.1007/s11899-016-0341-2","title":"Social Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM","year":2016,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AOP Orphan","keywords":"Social media; Hematologic Neoplasms; Social media analytics; Myeloproliferative neoplasm; Health care; Medicine; Public relations; Interpersonal communication; Internet privacy; Internal medicine; Political science; World Wide Web; Computer science; Sociology; Myelofibrosis; Social science; Cancer","score_opus":0.06264256132008802,"score_gpt":0.3193700999007866,"score_spread":0.2567275385806985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483061118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912324,0.005132982,0.00025752722,0.0022005325,0.0002262921,0.0006266884,0.00008055401,0.000032273598,0.00021075683],"genre_scores_gemma":[0.9975655,0.0013687802,0.00065655966,0.00009378436,0.00007036309,0.00008765615,0.00009296132,0.000017289842,0.00004708726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975984,0.00016857158,0.0010185011,0.00042112535,0.00051369175,0.00027970472],"domain_scores_gemma":[0.99626654,0.0016585536,0.0009683941,0.000647837,0.0003113736,0.00014730313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003817759,0.0003231227,0.0013734581,0.00025185404,0.00018498642,0.000014247899,0.00013125871,0.00014171652,0.00024492285],"category_scores_gemma":[0.0011388016,0.00016416922,0.00033118718,0.0009102101,0.00028577406,0.00007877261,0.0001570461,0.00022193554,0.000003831554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014800375,0.000572765,0.97920185,0.00012129095,0.0016168191,0.00011986257,0.0049863583,8.8706855e-7,0.00018749543,0.0016691863,0.0040425994,0.007332876],"study_design_scores_gemma":[0.0035657212,0.0003985479,0.9490213,0.0013153143,0.0050853053,0.00016462186,0.0013676364,0.00001845189,0.027249312,0.00680074,0.004579401,0.00043367225],"about_ca_topic_score_codex":0.000097450386,"about_ca_topic_score_gemma":0.00023969925,"teacher_disagreement_score":0.03018058,"about_ca_system_score_codex":0.000060456794,"about_ca_system_score_gemma":0.00015837912,"threshold_uncertainty_score":0.6694626},"labels":[],"label_agreement":null},{"id":"W2593332867","doi":"10.1007/s11899-017-0372-3","title":"New Treatment Strategies for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ponatinib; Medicine; Blinatumomab; Internal medicine; Oncology; Philadelphia chromosome; Dasatinib; Imatinib; Hematology; Chemotherapy; Lymphoblastic Leukemia; Leukemia; Chromosomal translocation; Myeloid leukemia","score_opus":0.11414245544969435,"score_gpt":0.400997813282527,"score_spread":0.2868553578328326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593332867","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046859896,0.98517436,0.00070717215,0.000062779065,0.002989222,0.008735799,0.00033865412,0.00037895856,0.001566196],"genre_scores_gemma":[0.00039610462,0.98826295,0.0008854234,0.000013896367,0.0009830605,0.0029185163,0.0035950493,0.000235043,0.0027099822],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99275595,0.00011351465,0.0026864891,0.0023961656,0.00067080633,0.0013770527],"domain_scores_gemma":[0.9917719,0.0003655818,0.0038594163,0.0029706894,0.00025173678,0.00078071054],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00022750211,0.0021507114,0.007478959,0.00041096375,0.00045848664,0.00025041963,0.00047015707,0.0010391243,0.00034368795],"category_scores_gemma":[0.00024338136,0.0014946263,0.0027372881,0.00026090935,0.00023372142,0.00027899104,0.00021964846,0.00048230548,0.00017611188],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00009151702,0.0005977214,0.00005195085,0.038805474,0.004338653,0.017737553,0.00011027114,0.0000011383696,0.000002505739,0.0010619449,0.010926391,0.9262749],"study_design_scores_gemma":[0.0027685573,0.0010418291,0.000010190192,0.060844567,0.017137319,0.04282511,0.00001569456,0.000009195249,0.000049735005,0.0012664119,0.8728881,0.0011433322],"about_ca_topic_score_codex":0.00007199289,"about_ca_topic_score_gemma":0.000009898168,"teacher_disagreement_score":0.92513156,"about_ca_system_score_codex":0.008420918,"about_ca_system_score_gemma":0.022784244,"threshold_uncertainty_score":0.99912333},"labels":[],"label_agreement":null},{"id":"W2595388903","doi":"10.1007/s11899-017-0368-z","title":"Current Review on High-Risk Multiple Myeloma","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Risk stratification; Disease; Intensive care medicine; Hematology; Internal medicine; Oncology; Risk assessment","score_opus":0.1741396546027891,"score_gpt":0.4409754810943322,"score_spread":0.26683582649154314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595388903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047085425,0.98592293,0.000014993346,0.00006615156,0.0035390232,0.008540868,0.00025910503,0.00031831342,0.0012915547],"genre_scores_gemma":[0.00023496561,0.99302894,0.00013444101,0.00002886779,0.00049711886,0.002606226,0.00269358,0.00016536957,0.0006104959],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908199,0.0006190381,0.0031002092,0.0024129732,0.0016026885,0.0014452435],"domain_scores_gemma":[0.9886177,0.0005041859,0.004748061,0.004726683,0.00038544767,0.0010178938],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001159309,0.0017613574,0.007892954,0.00051721605,0.00055541657,0.00011121782,0.0006567528,0.00056041655,0.00057427335],"category_scores_gemma":[0.0058332398,0.0011242277,0.0025135435,0.00039997586,0.0002681769,0.00012925733,0.00047018204,0.0021015415,0.0014335185],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022124652,0.000967336,0.0028337091,0.20023698,0.00039832175,0.008741729,0.0000034850957,1.5970379e-8,2.2093518e-8,0.00007479423,0.0159522,0.7707693],"study_design_scores_gemma":[0.0006063133,0.0002160422,0.00029599294,0.3276452,0.0025699828,0.0051023606,5.1306966e-7,0.0000012804607,0.0000029839812,0.00012519457,0.66282487,0.0006092503],"about_ca_topic_score_codex":0.00003287918,"about_ca_topic_score_gemma":0.000005856988,"teacher_disagreement_score":0.77016,"about_ca_system_score_codex":0.00047899762,"about_ca_system_score_gemma":0.0013102193,"threshold_uncertainty_score":0.9995132},"labels":[],"label_agreement":null},{"id":"W2766413477","doi":"10.1007/s11899-017-0421-y","title":"Rare Cancers and Social Media: Analysis of Twitter Metrics in the First 2 Years of a Rare-Disease Community for Myeloproliferative Neoplasms on Social Media—#MPNSM","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Social media; Social media analytics; Internet privacy; Field (mathematics); Health care; Categorization; Order (exchange); Analytics; Public relations; Medicine; Computer science; World Wide Web; Data science; Political science; Business","score_opus":0.41426121650310205,"score_gpt":0.48448902755134826,"score_spread":0.07022781104824621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766413477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029617691,0.95895284,0.0000030374958,0.0006125705,0.005276733,0.0049725883,0.00040136994,0.000031123058,0.00013203731],"genre_scores_gemma":[0.13044474,0.86436725,0.00003049546,0.00004213502,0.00072225224,0.0038121638,0.000547533,0.000030984793,0.0000024823755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99439615,0.0017896398,0.0017430374,0.00052156777,0.001018463,0.0005311563],"domain_scores_gemma":[0.98097956,0.013638865,0.004222663,0.00059724954,0.00041285716,0.00014878891],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003996682,0.00040214922,0.0029949944,0.00083672383,0.0012305351,0.00006432968,0.00073864206,0.0005628662,0.000024232753],"category_scores_gemma":[0.023551138,0.0003252162,0.0007883568,0.0017724592,0.0010715929,0.000108591514,0.00011249685,0.0007836235,7.439914e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060100654,0.00067894766,0.01851621,0.029205326,0.0006681706,0.000119517295,0.36324733,7.227959e-7,1.0134225e-8,0.0053051584,0.00370252,0.578496],"study_design_scores_gemma":[0.0008474909,0.000103198676,0.042704254,0.01401591,0.012025263,0.00001794517,0.027962856,0.000005161074,0.000001127995,0.009236177,0.89161116,0.0014694681],"about_ca_topic_score_codex":0.0008690724,"about_ca_topic_score_gemma":0.005575122,"teacher_disagreement_score":0.88790864,"about_ca_system_score_codex":0.0005423628,"about_ca_system_score_gemma":0.0027938422,"threshold_uncertainty_score":0.99992},"labels":[],"label_agreement":null},{"id":"W2766799159","doi":"10.1007/s11899-017-0424-8","title":"Social Media in Hematology in 2017: Dystopia, Utopia, or Somewhere In-between?","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dystopia; Hematology; Utopia; Internal medicine; Social media; Medicine; Political science; Law","score_opus":0.5896881544385401,"score_gpt":0.5592891715628737,"score_spread":0.030398982875666336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766799159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029667977,0.97204775,0.0000010224165,0.0004440811,0.01682202,0.0050115935,0.000012191483,0.00010987142,0.00258468],"genre_scores_gemma":[0.0038342727,0.9890305,0.00004418039,0.000010184452,0.0017381302,0.004983484,0.00014276637,0.0000611249,0.00015539475],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99000126,0.0019961898,0.0039333575,0.0014800243,0.0008826168,0.001706557],"domain_scores_gemma":[0.9902583,0.004489855,0.0038482617,0.00093975593,0.00014172737,0.00032212623],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004017987,0.0007858941,0.00526775,0.0011469002,0.00051196275,0.00010947334,0.0010959062,0.0021293228,0.00028863866],"category_scores_gemma":[0.018685434,0.00070271787,0.00044730806,0.0013317817,0.0007224998,0.00031387052,0.00023145192,0.0017952316,0.00010059525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000056522395,0.0003783151,0.107380845,0.020849146,0.000018947709,0.003959167,0.0151123265,2.3614524e-8,3.2372898e-9,0.015659982,0.0008932922,0.8357423],"study_design_scores_gemma":[0.00026612612,0.000014256544,0.0037324706,0.025873553,0.00009218554,0.00022606346,0.00063579617,1.02411214e-7,1.3487528e-7,0.008212428,0.9601809,0.000765984],"about_ca_topic_score_codex":0.0017603429,"about_ca_topic_score_gemma":0.037189003,"teacher_disagreement_score":0.9592876,"about_ca_system_score_codex":0.0015866689,"about_ca_system_score_gemma":0.0065930556,"threshold_uncertainty_score":0.9995424},"labels":[],"label_agreement":null},{"id":"W2767073213","doi":"10.1007/s11899-017-0422-x","title":"Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; European Hematology Association","keywords":"Social media; Context (archaeology); Medicine; Disease; Cancer; Family medicine; Internal medicine; Computer science; World Wide Web; Biology","score_opus":0.4136773431322619,"score_gpt":0.47976849415244993,"score_spread":0.06609115102018803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767073213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009292415,0.97182167,0.000053738313,0.00011415187,0.01221593,0.005401718,0.0005393592,0.00009068577,0.0004703523],"genre_scores_gemma":[0.086397916,0.908922,0.00012623555,0.000007764475,0.0006607258,0.002963566,0.0008281502,0.000064839885,0.000028784516],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929297,0.0015445201,0.0026966492,0.0007513773,0.0012656013,0.0008121824],"domain_scores_gemma":[0.9743905,0.016466668,0.006553065,0.001299626,0.0008162661,0.00047388018],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.002672385,0.000627137,0.0043565957,0.0012785565,0.0015259387,0.00006970246,0.0010368489,0.0007335031,0.00012605377],"category_scores_gemma":[0.04065958,0.00057673914,0.0018848025,0.0020543544,0.0008499201,0.00012728562,0.00018720097,0.0008692511,0.000009661886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014648239,0.0071811723,0.09853524,0.41107327,0.0028070463,0.00044120435,0.050581615,0.000007860828,1.1872532e-7,0.005991659,0.009505545,0.4137288],"study_design_scores_gemma":[0.0007109547,0.00015686864,0.002701187,0.029465659,0.029235419,0.000019450466,0.0036935725,0.000016046895,0.000008914284,0.003952549,0.9282983,0.0017411102],"about_ca_topic_score_codex":0.00029751423,"about_ca_topic_score_gemma":0.0006399494,"teacher_disagreement_score":0.9187927,"about_ca_system_score_codex":0.00051558414,"about_ca_system_score_gemma":0.0024670754,"threshold_uncertainty_score":0.9997739},"labels":[],"label_agreement":null},{"id":"W2801721440","doi":"10.1007/s11899-018-0449-7","title":"Tyrosine Kinase Inhibitors in the Treatment of Chronic-Phase CML: Strategies for Frontline Decision-making","year":2018,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Bosutinib; Nilotinib; Dasatinib; Medicine; Imatinib; Oncology; Disease; Tyrosine kinase; Imatinib mesylate; Tyrosine-kinase inhibitor; Internal medicine; Myeloid leukemia; Toxicity; Pharmacology; Intensive care medicine; Cancer","score_opus":0.07998761122677826,"score_gpt":0.4216340902875697,"score_spread":0.34164647906079143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801721440","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002819352,0.9866053,0.00043774865,0.000020870875,0.0018538086,0.00787125,0.00012470057,0.00008386893,0.00018310599],"genre_scores_gemma":[0.008243018,0.9866268,0.00096058846,0.000008559495,0.00076100667,0.0025010381,0.0007533219,0.000102468555,0.000043183576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936889,0.0001823548,0.003346301,0.0013365756,0.00064827874,0.0007975989],"domain_scores_gemma":[0.99415034,0.0009516115,0.0025891063,0.0019410608,0.00022579783,0.00014207877],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000618639,0.0011499883,0.0044214507,0.00046221638,0.00012530551,0.0000555824,0.00030915294,0.00054048223,0.000148856],"category_scores_gemma":[0.0004287186,0.0006400202,0.0014936818,0.00063643954,0.0002663317,0.00011045753,0.000079029196,0.00030537543,0.000017380245],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011406206,0.005416133,0.0001622694,0.031107808,0.00030981976,0.004231449,0.0002627292,0.0000011879365,0.0000011542693,0.0002844291,0.0034589726,0.95465],"study_design_scores_gemma":[0.0038631484,0.0033111852,0.0000065536965,0.10404025,0.0029110294,0.0047438936,0.00009474147,0.00003770668,0.000041920255,0.0014244418,0.8789709,0.00055422296],"about_ca_topic_score_codex":0.000025682819,"about_ca_topic_score_gemma":0.00005534336,"teacher_disagreement_score":0.9540958,"about_ca_system_score_codex":0.002312282,"about_ca_system_score_gemma":0.0033084787,"threshold_uncertainty_score":0.9996051},"labels":[],"label_agreement":null},{"id":"W2895867440","doi":"10.1007/s11899-018-0490-6","title":"Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN—Increasing Exposure over Two Years Since Inception of a Disease-Specific Twitter Community","year":2018,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; European Hematology Association","keywords":"Social media; Disease; Medicine; Health care; Order (exchange); Political science; Internal medicine; Computer science; Business; World Wide Web","score_opus":0.09026787319341162,"score_gpt":0.34961401856504704,"score_spread":0.2593461453716354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895867440","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14047432,0.8548023,0.000018840332,0.000020150024,0.0022992615,0.0014058957,0.00012170127,0.00015585838,0.00070165837],"genre_scores_gemma":[0.34889415,0.6494744,0.000040563915,0.00004243307,0.00044155802,0.00017489694,0.0007814217,0.000109406465,0.00004121089],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99378276,0.001017426,0.0022494013,0.001013684,0.0010926881,0.0008440178],"domain_scores_gemma":[0.99465346,0.0007846829,0.0027163615,0.001176032,0.00027008113,0.00039936358],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008682212,0.0009932452,0.0034178854,0.00041663583,0.00036324232,0.00006112042,0.00034421074,0.0006176386,0.00029398082],"category_scores_gemma":[0.00073196186,0.0008584929,0.0012323956,0.0006387612,0.0005303872,0.0001155638,0.00023456152,0.0015980764,0.00009133933],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002477648,0.014769786,0.022178126,0.26316836,0.0017800949,0.016929058,0.006288469,0.000010719301,0.00007878727,0.0011905831,0.096618004,0.57451034],"study_design_scores_gemma":[0.008811344,0.001300174,0.007333769,0.20680901,0.010013179,0.00371081,0.000899818,0.000015547446,0.00008320204,0.0035871987,0.7531327,0.004303221],"about_ca_topic_score_codex":0.000028593126,"about_ca_topic_score_gemma":0.000018262577,"teacher_disagreement_score":0.6565147,"about_ca_system_score_codex":0.0006174846,"about_ca_system_score_gemma":0.00089268177,"threshold_uncertainty_score":0.9993866},"labels":[],"label_agreement":null},{"id":"W2913763056","doi":"10.1007/s11899-019-0498-6","title":"Industry’s Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy","year":2019,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"NIH Clinical Center; Novartis Pharmaceuticals Corporation; University of Pennsylvania","keywords":"Chimeric antigen receptor; Medicine; Immunotherapy; Hematology; Cytokine release syndrome; Internal medicine; Clinical trial; Oncology; Cancer","score_opus":0.09754620024724776,"score_gpt":0.37582670228071946,"score_spread":0.2782805020334717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913763056","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029150108,0.9828251,0.00005240909,0.00007509598,0.004060277,0.0073730373,0.000025551672,0.00055528653,0.0021182387],"genre_scores_gemma":[0.00036987505,0.9890337,0.00028189234,0.00006786306,0.0007002603,0.00079842383,0.0010565985,0.00058078853,0.0071106106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9896409,0.000681273,0.0035561188,0.0027094746,0.0016316683,0.0017805614],"domain_scores_gemma":[0.99172366,0.00027032476,0.002986685,0.0040081562,0.0003949351,0.0006162602],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0016129664,0.0020239362,0.0070192544,0.00094453734,0.0003071552,0.00018110177,0.00091393554,0.0030473268,0.008560743],"category_scores_gemma":[0.0001672154,0.0015186542,0.0025618032,0.001626505,0.00036500185,0.00018733714,0.0004268435,0.005482815,0.0011689189],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008501563,0.0010284887,0.0015063789,0.040724058,0.00079289044,0.0028139704,0.00029364743,3.0113674e-7,0.0042185015,0.000027648448,0.0045793126,0.9439298],"study_design_scores_gemma":[0.00092287443,0.0003717445,0.000017167351,0.023653032,0.00047197903,0.003932106,0.000041087085,0.0000030170156,0.0034841003,0.00006927982,0.96558404,0.0014495952],"about_ca_topic_score_codex":0.00013214012,"about_ca_topic_score_gemma":0.0000020195,"teacher_disagreement_score":0.96100473,"about_ca_system_score_codex":0.0007562988,"about_ca_system_score_gemma":0.0025921122,"threshold_uncertainty_score":0.9996088},"labels":[],"label_agreement":null},{"id":"W3008063389","doi":"10.1007/s11899-020-00560-x","title":"Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia","year":2020,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Chronic myelogenous leukemia; Medicine; Tyrosine kinase; Hematology; Dasatinib; Toxicity; Internal medicine; Tyrosine-kinase inhibitor; breakpoint cluster region; Imatinib; Leukemia; Cancer research; Pharmacology; Oncology; Receptor; Myeloid leukemia; Cancer","score_opus":0.04617367194453772,"score_gpt":0.3129403496724175,"score_spread":0.2667666777278798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008063389","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016329131,0.9920624,0.00022043163,0.000010131457,0.001147104,0.0044115814,0.00008409366,0.00012661242,0.0003047424],"genre_scores_gemma":[0.02502425,0.9732759,0.00038474752,0.000006175726,0.00016005932,0.0004662594,0.00050740666,0.00013930385,0.000035886853],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912453,0.00036444564,0.004487057,0.0017546249,0.0012509676,0.00089759595],"domain_scores_gemma":[0.99357647,0.00015555574,0.0032657695,0.002387289,0.0002424963,0.000372404],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0008624703,0.0013160935,0.009900083,0.00060833216,0.00005434729,0.000011308701,0.00038274063,0.00094390236,0.0001687342],"category_scores_gemma":[0.0006374392,0.0010524144,0.0032593284,0.0014306218,0.00025831143,0.00008007404,0.00044155747,0.0010305982,0.000026901776],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000038307546,0.0008339057,0.00024440125,0.21513627,0.0025933401,0.026049487,0.00010169481,0.000031627245,0.00020978764,0.00056063005,0.0003913304,0.7538092],"study_design_scores_gemma":[0.0034673577,0.001323264,0.00003840426,0.19613938,0.013740008,0.021054063,0.000033238706,0.000035665096,0.015416181,0.0011186915,0.74586385,0.0017699125],"about_ca_topic_score_codex":0.00014145768,"about_ca_topic_score_gemma":0.000009934328,"teacher_disagreement_score":0.7520393,"about_ca_system_score_codex":0.006269491,"about_ca_system_score_gemma":0.008346957,"threshold_uncertainty_score":0.99995905},"labels":[],"label_agreement":null},{"id":"W4282946191","doi":"10.1007/s11899-022-00663-7","title":"Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies","year":2022,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"Canadian Institutes of Health Research","keywords":"CHEK2; Germline; Myeloid leukemia; Myeloid; Germline mutation; Biology; Chronic lymphocytic leukemia; Leukemia; Cancer research; Immunology; Genetics; Mutation; Gene","score_opus":0.0919673839579153,"score_gpt":0.37176420474396765,"score_spread":0.27979682078605234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282946191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027965908,0.99148995,0.000010878314,0.000092021604,0.0005917481,0.0032387336,0.000050004946,0.00015981871,0.0015702448],"genre_scores_gemma":[0.0004833259,0.9965495,0.0002700978,0.00009234695,0.0001359312,0.0011579923,0.00018762027,0.0001624825,0.00096072134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99324083,0.0004204214,0.0024659312,0.0019154386,0.0008494781,0.0011079046],"domain_scores_gemma":[0.9964081,0.0004380398,0.001250239,0.0013633292,0.000082916085,0.00045738913],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016396932,0.0011038146,0.004731006,0.00077446137,0.00018909965,0.00007984243,0.00027640446,0.00059966993,0.0012845877],"category_scores_gemma":[0.00090023736,0.0008512886,0.00044503753,0.0009957631,0.00039957033,0.00011167671,0.000990537,0.0016944319,0.00003625103],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007088512,0.0010405252,0.016316313,0.22656319,0.0004766575,0.05414483,0.0006864679,1.763155e-7,0.000011521538,0.0028953317,0.005116692,0.69267744],"study_design_scores_gemma":[0.0005637332,0.00012520998,0.00020741248,0.023972988,0.0006303378,0.08167792,0.000048306432,0.0000079597885,0.0000063343773,0.0007193826,0.89129317,0.0007472298],"about_ca_topic_score_codex":0.00003611916,"about_ca_topic_score_gemma":0.000006487584,"teacher_disagreement_score":0.88617647,"about_ca_system_score_codex":0.0005017669,"about_ca_system_score_gemma":0.0012019696,"threshold_uncertainty_score":0.99962837},"labels":[],"label_agreement":null},{"id":"W4309706624","doi":"10.1007/s11899-022-00682-4","title":"The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma","year":2022,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Multiple myeloma; Clinical trial; Oncology; Nausea; Internal medicine; Vomiting","score_opus":0.07597734830097738,"score_gpt":0.36046075590868615,"score_spread":0.28448340760770874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309706624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016471748,0.99380666,0.0000013206025,0.000022432147,0.00035322658,0.0029780515,0.00005598223,0.00005559811,0.0010795732],"genre_scores_gemma":[0.0051393537,0.9929131,0.000093425835,0.000003594452,0.000051113595,0.0010583829,0.00046774672,0.000057539728,0.00021571711],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952843,0.0003873654,0.0019604748,0.0008957885,0.0007572944,0.0007147867],"domain_scores_gemma":[0.9964181,0.0009466522,0.0012406273,0.001049397,0.0000893392,0.00025588527],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009166665,0.00060703186,0.0026799499,0.00032241273,0.00023547403,0.000029500085,0.00024522227,0.00024015062,0.00022394296],"category_scores_gemma":[0.0013235821,0.00035784327,0.00051695755,0.0005369662,0.00020838856,0.000048056223,0.0005012256,0.0008138148,0.000012024891],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047858884,0.0004577383,0.03752048,0.014029526,0.00022721833,0.0040760273,0.00004410506,5.0778077e-8,0.0000012329097,0.0001805152,0.0002187066,0.94319654],"study_design_scores_gemma":[0.0007005832,0.00015070081,0.00066550827,0.009146392,0.0004643027,0.010001452,0.000077345045,0.000021731352,0.000029119095,0.00044285328,0.9780016,0.00029840338],"about_ca_topic_score_codex":0.00005876393,"about_ca_topic_score_gemma":0.000027122152,"teacher_disagreement_score":0.9777829,"about_ca_system_score_codex":0.0001796397,"about_ca_system_score_gemma":0.00056874927,"threshold_uncertainty_score":0.99988735},"labels":[],"label_agreement":null},{"id":"W4376641118","doi":"10.1007/s11899-023-00698-4","title":"A Pragmatic Approach to Managing Long-Term Adverse Effects in Chronic Myeloid Leukemia Treatment","year":2023,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myeloid leukemia; Adverse effect; Hematology; Oncology; Internal medicine; Population; Intensive care medicine","score_opus":0.0647491682968343,"score_gpt":0.36325252237516004,"score_spread":0.29850335407832573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376641118","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017708791,0.97803414,0.00013887066,0.000015927433,0.0015503749,0.01582302,0.000021114074,0.00070479733,0.0019408959],"genre_scores_gemma":[0.00063399045,0.9847918,0.0004576086,0.000017752347,0.0003421655,0.010035128,0.0017664478,0.0003177743,0.0016373312],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99076515,0.0004023384,0.003331102,0.0028094016,0.0009269122,0.0017651189],"domain_scores_gemma":[0.99424726,0.0004228564,0.0018104546,0.0027227313,0.0000811493,0.0007155654],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00065291626,0.0020467178,0.0071390932,0.0014358878,0.0001387941,0.00005486443,0.0004041932,0.0007637815,0.00007617193],"category_scores_gemma":[0.00042422244,0.0015125223,0.0015514478,0.001958446,0.00011418839,0.00012544695,0.0004557926,0.0009526395,0.00087783934],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000022342154,0.0009978533,0.0024519481,0.32129973,0.0009946736,0.046202984,0.0002028265,0.000024985678,9.52008e-7,0.00016743931,0.0005363067,0.62709796],"study_design_scores_gemma":[0.0073373667,0.00159624,0.0019279162,0.63998306,0.013105675,0.05539084,0.000041651252,0.00018657734,0.000029535891,0.00042164742,0.27610075,0.003878731],"about_ca_topic_score_codex":0.00006327074,"about_ca_topic_score_gemma":0.00003552903,"teacher_disagreement_score":0.62321925,"about_ca_system_score_codex":0.028435381,"about_ca_system_score_gemma":0.0060831774,"threshold_uncertainty_score":0.9999001},"labels":[],"label_agreement":null},{"id":"W4402312879","doi":"10.1007/s11899-024-00742-x","title":"Advances in Stem Cell Transplantation for Myelofibrosis","year":2024,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Medicine; Transplantation; Hematology; Stem cell; Internal medicine; Oncology; Intensive care medicine; Biology; Bone marrow; Genetics","score_opus":0.06258721104371225,"score_gpt":0.38268654524185536,"score_spread":0.3200993341981431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402312879","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009298301,0.99121815,0.00013416725,0.00003168032,0.001640487,0.0051465146,0.00013151752,0.00013367015,0.0014708301],"genre_scores_gemma":[0.0005580872,0.99160904,0.00030224182,0.000010509767,0.00012423554,0.005950626,0.0010561218,0.00008039326,0.00030876993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959655,0.00009178255,0.0018735512,0.0012275217,0.00034071566,0.00050095946],"domain_scores_gemma":[0.9981958,0.00025513297,0.0007974488,0.00049491704,0.0000959568,0.00016071611],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028670923,0.00080549845,0.0031443401,0.00040271884,0.00006512912,0.00004626353,0.000088750654,0.0003677018,0.000052381718],"category_scores_gemma":[0.000026320557,0.00052283134,0.0009828836,0.00044564166,0.00004558665,0.000110893205,0.000032059066,0.0003650797,0.000060694216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018857143,0.0004652299,0.00081239216,0.26745886,0.000069244044,0.0040860143,0.00007997743,2.7984916e-7,2.0904322e-7,0.00067183777,0.000805203,0.7255319],"study_design_scores_gemma":[0.00039766825,0.00023012125,0.000015823425,0.10112011,0.0036912863,0.005273693,0.000014804796,0.0000027207534,0.00009067977,0.0005207482,0.8881725,0.0004698425],"about_ca_topic_score_codex":0.0000016816971,"about_ca_topic_score_gemma":0.0000065727445,"teacher_disagreement_score":0.8873673,"about_ca_system_score_codex":0.00023691557,"about_ca_system_score_gemma":0.00043656415,"threshold_uncertainty_score":0.9997223},"labels":[],"label_agreement":null},{"id":"W4413100643","doi":"10.1007/s11899-025-00754-1","title":"Allogeneic Transplant for CMML","year":2025,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hematology; Internal medicine; Oncology; Intensive care medicine","score_opus":0.09515401914913654,"score_gpt":0.4224962066267783,"score_spread":0.32734218747764177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413100643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000063353923,0.98661435,0.0008896386,0.00008905473,0.0019126046,0.007446067,0.00021898498,0.00027862794,0.0025443295],"genre_scores_gemma":[0.00001948432,0.98839587,0.0006437455,0.00004857144,0.00028401092,0.0035719029,0.0025620433,0.00009707207,0.00437728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994183,0.00017276281,0.0023674427,0.0016176143,0.0005780633,0.0010811428],"domain_scores_gemma":[0.99606246,0.0006263771,0.0010127099,0.0016300887,0.000299312,0.00036907935],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008483907,0.0009990777,0.005081754,0.0006327694,0.0001579543,0.000040985702,0.00039320203,0.0008902038,0.00022290196],"category_scores_gemma":[0.00082962343,0.000703912,0.0020934853,0.0007032195,0.00014803643,0.00004863843,0.00017190637,0.0009612416,0.00007585715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026593354,0.00025663842,0.00014167359,0.3063121,0.00038476547,0.005350171,0.000014750041,3.7879886e-8,0.0000011185623,0.0008182345,0.037458416,0.6492355],"study_design_scores_gemma":[0.00039259598,0.00010453421,0.0000021090373,0.09573487,0.0029691097,0.016990097,0.0000025979232,0.0000020217285,0.000025210395,0.00046455875,0.8827888,0.0005235142],"about_ca_topic_score_codex":0.000002849396,"about_ca_topic_score_gemma":0.0000013501466,"teacher_disagreement_score":0.84533036,"about_ca_system_score_codex":0.0004871808,"about_ca_system_score_gemma":0.0040500453,"threshold_uncertainty_score":0.9995412},"labels":[],"label_agreement":null},{"id":"W4415987224","doi":"10.1007/s11899-025-00764-z","title":"Transforming the Treatment of Acute Lymphoblastic Leukemia: the Role of Bispecific Antibodies, Antibody-Drug Conjugates, and CAR T-cell Therapy","year":2025,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Blinatumomab; Chimeric antigen receptor; Ponatinib; Immunotherapy; Hematology; Minimal residual disease; Chemotherapy","score_opus":0.03765103770373049,"score_gpt":0.34985800668731853,"score_spread":0.312206968983588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415987224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007804587,0.98449033,0.000011633464,0.000035119043,0.000578867,0.0054900693,0.000103164166,0.000067949986,0.0014182893],"genre_scores_gemma":[0.00560227,0.9925035,0.000018393419,0.000006822223,0.00009012566,0.00038457746,0.0002023366,0.000077704455,0.0011142698],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99519175,0.000358428,0.00217328,0.00092385826,0.00071314175,0.0006395133],"domain_scores_gemma":[0.99554056,0.0009655469,0.0014394647,0.0016544135,0.00026091893,0.0001390772],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067285204,0.0008997026,0.0040207603,0.00032036417,0.00021082074,0.000038010967,0.00037270342,0.00034123965,0.00020627263],"category_scores_gemma":[0.00004872687,0.00041733246,0.0012697629,0.0007245983,0.000726948,0.000046659243,0.0000897747,0.00045754304,0.000003503768],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012749094,0.0008939296,0.0018078088,0.033501495,0.0015594112,0.00086581206,0.0007905782,3.3022886e-7,0.0013158014,0.00037841956,0.0002369252,0.958522],"study_design_scores_gemma":[0.0010888547,0.00053400436,0.00001883434,0.023118827,0.0031727443,0.0039650486,0.00018169427,0.000006786236,0.00903216,0.00029480408,0.95819235,0.00039386677],"about_ca_topic_score_codex":0.000104574356,"about_ca_topic_score_gemma":0.000006204569,"teacher_disagreement_score":0.95812815,"about_ca_system_score_codex":0.00031705768,"about_ca_system_score_gemma":0.0018631427,"threshold_uncertainty_score":0.99982786},"labels":[],"label_agreement":null},{"id":"W818882356","doi":"10.1007/s11899-015-0272-3","title":"Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Flow cytometry; Bone marrow; Hematology; International Prognostic Scoring System; Internal medicine; Biopsy; Pathology; Cytology; Oncology; Immunology","score_opus":0.15034249218147458,"score_gpt":0.4220731153203322,"score_spread":0.27173062313885765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W818882356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004839427,0.9840918,0.00008063438,0.000025662848,0.0003140311,0.009893732,0.00012494011,0.000031762775,0.00059798465],"genre_scores_gemma":[0.02136781,0.97161466,0.00046195788,0.000020699203,0.0001054038,0.00434768,0.0018669477,0.00012184269,0.00009300842],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938928,0.00052498997,0.0017173591,0.00088912784,0.0023878096,0.0005879354],"domain_scores_gemma":[0.9948525,0.00046073474,0.0016679334,0.001351399,0.0015142903,0.00015318416],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039057406,0.0006197383,0.0029001157,0.00058771984,0.000057618756,0.000026618029,0.00036894553,0.00042348844,0.00015753505],"category_scores_gemma":[0.0018005535,0.00031849399,0.00046919603,0.0012635551,0.00014310099,0.00008211525,0.000121273166,0.0006863027,0.00002300117],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012204348,0.0012962612,0.018369189,0.08632341,0.0004375117,0.00061665813,0.0003471429,0.0000028464303,8.549407e-8,0.000062960986,0.0064290226,0.8859929],"study_design_scores_gemma":[0.0048162974,0.0013102969,0.003310402,0.09504223,0.008648788,0.006424286,0.000167672,0.0005438673,0.000005398946,0.0017243504,0.87697476,0.0010316524],"about_ca_topic_score_codex":0.0000037072525,"about_ca_topic_score_gemma":0.0000018134451,"teacher_disagreement_score":0.88496125,"about_ca_system_score_codex":0.00068709994,"about_ca_system_score_gemma":0.0031436002,"threshold_uncertainty_score":0.9999267},"labels":[],"label_agreement":null}]}